News and Insights

Welcome to Bellberry’s blog. Here we publish commentary, updates, feature posts and thought leadership on research ethics, regulation, participant experience and system change. Discover what’s happening across the research and ethics landscape in Australia and beyond.

Oct 19, 2023

From Lab To Life Podcast: Episode 1

Listen to our brand new podcast series, ‘From Lab To Life’, where we go behind the scenes to understand more about the clinical trial and medical research sector.  You’ll hear from experts in the sector, including researchers, clinical trial participants and members of Human Research Ethics Committees, exploring challenges and opportunities facing the health and medical […]

Read More
Oct 3, 2023

International Symposium Statement Released

In June 2023 Bellberry were delighted to host the “Towards a Coordinated Approach for Managing Accelerated Patient Access to Potentially Beneficial Medicines: Balancing Patient, Regulator, Health Technology Assessment (HTA), Payer, and Other Stakeholder Needs” international workshop in Adelaide. This event brought together over a global delegation from over 20 nations including the US, UK, Europe, Canada, Singapore, […]

Read More
Sep 25, 2023

Bellberry Not-For-Profit Business of the Year Award Winners!

  Bellberry were thrilled to win the 2023 Not-For-Profit Business of the Year Award at Friday’s South Australian Premier’s Business and Export Awards! What a great way to kick off our 20th year celebrations – thanks to our amazing Bellberry community.

Read More
May 22, 2023

Bellberry Clinical Trial Activity Report for 2022

On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report for 2022. This annual publication represents over one third of the Australia wide CTN trial activity across the development lifecycle. This report demonstrates capability and capacity in a broad range of research areas. It also captures the originating funding location […]

Read More
Jul 8, 2022

Quality update: progress and final reporting refresher

Progress reporting realignment initiative During 2021 Bellberry implemented a new approach to annual reporting, making use of technology solutions to improve performance. The primary objectives of the project were to: Support researchers maintain compliance with the terms and conditions of ethical approval and obligations under the National Statement on Ethical Conduct in Human Research.  Move […]

Read More
May 20, 2022

Bellberry Clinical Trial Activity Report 2021

On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report 2021. This second annual publication represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates capability and capacity in a broad range of research areas. The report also captures the originating funding location […]

Read More
Nov 16, 2021

Bellberry Quality Update: HREC membership lists

As per the National Statement on Ethical Conduct in Human Research (2007) Updated 2018, at the end of each HREC meeting, Bellberry Administration creates a ‘Member List’ as per the example below: The member composition at the meeting may change from protocol to protocol, in consideration of the expertise required and conflicts of interest. The […]

Read More
Nov 10, 2021

Safety reporting requirements update

  As most of our users have now formalised local governance processes for internal safety reporting, we have updated MAR G2 Safety reporting, to no longer require the submission of SUSARs for individual events at Bellberry sites. To assist sites in understanding the updated requirements, if Bellberry’s administrative team receives documentation not outlined in MAR […]

Read More
Sep 27, 2021

Progress and Final Reporting Refresher

Progress reporting realignment initiative We have seen significant improvement with compliance since Bellberry began a significant progress reporting realignment initiative. The primary objectives of the project were to: Progress and final reporting: guidance materials Bellberry provides the following documents relating to progress and final reporting: MAR G4 Progress and final reports This guidance outlines researcher […]

Read More
May 20, 2021

Bellberry Clinical Trial Activity Report 2020

  Bellberry is the largest independent reviewer of CTN trials in Australia. This year on Clinical Trials Day, we’re pleased to share a summary report which describes research activity overseen by Bellberry HRECs through 2020. This activity report represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates […]

Read More
Mar 26, 2021

Process changes at Bellberry

It is now several months since Bellberry updated its procedures and we are pleased to report that there has been a significant drop in start-up times for additional sites. The table beneath is a comparator of Jan/Mar 2020 to 2021. These months have been chosen as Jan/Mar may pre-date any COVID related issues sites may […]

Read More
May 27, 2020

Bellberry receives Australian first recognition

Bellberry awarded AAHRPP accreditation Bellberry has become the first organisation in Australia to achieve international accreditation for excellence and ethically sound processes in running Human Research Ethics Committees (HRECs). The recognition has come from the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is based in the USA. The AAHRPP site accreditation team […]

Read More
Apr 30, 2018

Launch of Exciting New Australian Clinical Trials Initiative, CT:IQ!

We are delighted to announce that Bellberry, ACTA, NHMRC CTC and The George Institute have formed a consortium ‘Clinical Trials: Impact & Quality (CT:IQ)’. The consortium’s mission is “to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of […]

Read More
Sep 8, 2016

Crossover Conference Papers Published

In October 2014 Bellberry hosted the Crossover conference, an international expert scientific meeting that addressed the challenges of early treatment switching in clinical trial design for oncology.  A further scientific meeting in 2015 allowed for the development and launch of best practice guidelines for trial design and statistical methods from an international expert panel. Bellberry […]

Read More